Switch theme
Sign up to access all valuation multiples
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola’s operations are divided into two segments which include distribution and wholesale.
2006
934
LTM Revenue $2.0B
LTM EBITDA $34.0M
$147M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Oriola has a last 12-month revenue (LTM) of $2.0B and a last 12-month EBITDA of $34.0M.
In the most recent fiscal year, Oriola achieved revenue of $1.9B and an EBITDA of -$0.8M.
Oriola expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Oriola valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | XXX | $1.9B | XXX | XXX | XXX |
| Gross Profit | $261M | XXX | $180M | XXX | XXX | XXX |
| Gross Margin | 13% | XXX | 10% | XXX | XXX | XXX |
| EBITDA | $34.0M | XXX | -$0.8M | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| EBIT | $18.3M | XXX | $15.2M | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | -$13.0M | XXX | -$22.6M | XXX | XXX | XXX |
| Net Margin | -1% | XXX | -1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Oriola's stock price is EUR 1 (or $1).
Oriola has current market cap of EUR 196M (or $220M), and EV of EUR 131M (or $147M).
See Oriola trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $147M | $220M | XXX | XXX | XXX | XXX | $-0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Oriola has market cap of $220M and EV of $147M.
Oriola's trades at 0.1x EV/Revenue multiple, and -187.3x EV/EBITDA.
Equity research analysts estimate Oriola's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Oriola has a P/E ratio of -16.8x.
See valuation multiples for Oriola and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $220M | XXX | $220M | XXX | XXX | XXX |
| EV (current) | $147M | XXX | $147M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | 4.3x | XXX | -187.3x | XXX | XXX | XXX |
| EV/EBIT | 8.0x | XXX | 9.7x | XXX | XXX | XXX |
| EV/Gross Profit | 0.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | -16.8x | XXX | -9.7x | XXX | XXX | XXX |
| EV/FCF | 4.5x | XXX | 3.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOriola's last 12 month revenue growth is 8%
Oriola's revenue per employee in the last FY averaged $2.0M, while opex per employee averaged $0.2M for the same period.
Oriola's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Oriola's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Oriola and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | 9% | XXX | 8% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $2.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Oriola acquired XXX companies to date.
Last acquisition by Oriola was XXXXXXXX, XXXXX XXXXX XXXXXX . Oriola acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Oriola founded? | Oriola was founded in 2006. |
| Where is Oriola headquartered? | Oriola is headquartered in Finland. |
| How many employees does Oriola have? | As of today, Oriola has 934 employees. |
| Who is the CEO of Oriola? | Oriola's CEO is Ms. Katarina Gabrielson. |
| Is Oriola publicy listed? | Yes, Oriola is a public company listed on HEL. |
| What is the stock symbol of Oriola? | Oriola trades under OKDAV ticker. |
| When did Oriola go public? | Oriola went public in 2006. |
| Who are competitors of Oriola? | Similar companies to Oriola include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Oriola? | Oriola's current market cap is $220M |
| What is the current revenue of Oriola? | Oriola's last 12 months revenue is $2.0B. |
| What is the current revenue growth of Oriola? | Oriola revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Oriola? | Current revenue multiple of Oriola is 0.1x. |
| Is Oriola profitable? | Yes, Oriola is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Oriola? | Oriola's last 12 months EBITDA is $34.0M. |
| What is Oriola's EBITDA margin? | Oriola's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Oriola? | Current EBITDA multiple of Oriola is 4.3x. |
| What is the current FCF of Oriola? | Oriola's last 12 months FCF is $32.6M. |
| What is Oriola's FCF margin? | Oriola's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Oriola? | Current FCF multiple of Oriola is 4.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
